Long-term safety of botulinum toxin type A

Mov Disord. 2003 Sep;18(9):1080-1. doi: 10.1002/mds.10495.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Botulinum Toxins, Type A / adverse effects*
  • Botulinum Toxins, Type A / therapeutic use
  • Clinical Trials as Topic
  • Humans
  • Nervous System Diseases / therapy*
  • Neuromuscular Agents / adverse effects*
  • Neuromuscular Agents / therapeutic use
  • Time Factors
  • Treatment Outcome

Substances

  • Neuromuscular Agents
  • Botulinum Toxins, Type A